|
TRIM27 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.237600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.136600E-01 |
| Normal-vs-Stage2 |
5.798800E-01 |
| Normal-vs-Stage3 |
4.832000E-01 |
| Normal-vs-Stage4 |
1.509450E-01 |
| Stage1-vs-Stage2 |
9.537600E-01 |
| Stage1-vs-Stage3 |
8.374000E-01 |
| Stage1-vs-Stage4 |
2.709600E-01 |
| Stage2-vs-Stage3 |
9.351200E-01 |
| Stage2-vs-Stage4 |
4.391200E-01 |
| Stage3-vs-Stage4 |
4.274400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.916200E-01 |
| Normal-vs-AfricanAmerican |
9.251600E-01 |
| Normal-vs-Asian |
1.846160E-01 |
| Caucasian-vs-AfricanAmerican |
5.378200E-01 |
| Caucasian-vs-Asian |
2.824800E-01 |
| AfricanAmerican-vs-Asian |
2.089800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.434800E-01 |
| Normal-vs-Female |
2.666600E-01 |
| Male-vs-Female |
2.189200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.579000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.870400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.195600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.191200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.628000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.216800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.801400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.074000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.982800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.815200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.301800E-03 |
| Classical-VS-Follicular |
1.772080E-02 |
| Classical-VS-Other |
4.908800E-01 |
| Classical-VS-Normal |
9.781400E-01 |
| Tall-VS-Follicular |
6.764000E-01 |
| Tall-VS-Other |
7.441000E-01 |
| Tall-VS-Normal |
3.191700E-02 |
| Follicular-VS-Other |
8.471000E-01 |
| Follicular-VS-Normal |
6.393600E-02 |
| Other-VS-Normal |
5.029200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.988800E-01 |
| Normal-vs-N1 |
3.866000E-02 |
| N0-vs-N1 |
7.723500E-02 |
|
|
